Milestone Pharmaceuticals Inc.
MIST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $193 | $129 | $53 | $147 |
| - Cash | $47 | $42 | $45 | $25 |
| + Debt | $57 | $56 | $56 | $55 |
| Enterprise Value | $204 | $143 | $64 | $176 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$12 | -$20 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$13 | -$21 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.2 | -0.31 | -0.2 |
| % Growth | 40% | 35.5% | -55% | – |
| Operating Cash Flow | -$10 | -$13 | -$14 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$13 | -$14 | -$7 |